本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CRISPR Therapeutics AG

68.14
+2.213.35%
盘后68.260.1200+0.18%19:08 EDT
成交量:378.48万
成交额:2.57亿
市值:58.85亿
市盈率:-15.09
高:69.58
开:67.91
低:66.31
收:65.93
数据加载中...
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report